CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $789,000 | -88.7% | 890,000 | -88.1% | 0.00% | -83.3% |
| Q3 2018 | $7,003,000 | -63.3% | 7,500,000 | -57.7% | 0.01% | -68.4% |
| Q2 2018 | $19,058,000 | +50.4% | 17,727,000 | +62.0% | 0.02% | +58.3% |
| Q1 2018 | $12,672,000 | +5.3% | 10,942,000 | +22.4% | 0.01% | +9.1% |
| Q4 2017 | $12,031,000 | -42.9% | 8,941,000 | -34.6% | 0.01% | -45.0% |
| Q3 2017 | $21,077,000 | -21.2% | 13,675,000 | -13.4% | 0.02% | -23.1% |
| Q2 2017 | $26,733,000 | +144.0% | 15,795,000 | +85.6% | 0.03% | +160.0% |
| Q1 2017 | $10,957,000 | +27.5% | 8,510,000 | +1.7% | 0.01% | +11.1% |
| Q4 2016 | $8,594,000 | -17.8% | 8,364,000 | -24.4% | 0.01% | -10.0% |
| Q3 2016 | $10,454,000 | +22.6% | 11,062,000 | +5574.5% | 0.01% | +11.1% |
| Q2 2016 | $8,526,000 | – | 194,941 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 84,846,000 | $114,699,000 | 3.39% |
| SYMPHONY ASSET MANAGEMENT LLC | 6,000,000 | $8,104,000 | 0.82% |
| ZAZOVE ASSOCIATES LLC | 10,100,000 | $13,682,000 | 0.81% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 14,074,000 | $19,008,000 | 0.54% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 5,000,000 | $6,728,000 | 0.43% |
| CSS LLC/IL | 6,251,000 | $8,433,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 3,032,000 | $4,080,000 | 0.34% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,328,000 | $9,903,000 | 0.19% |
| Nicholas Investment Partners, LP | 1,620,000 | $2,180,000 | 0.07% |
| D. E. Shaw & Co., Inc. | 34,550,000 | $46,670,000 | 0.06% |